相似文献
1
Optimizing Immunization Strategies for Individuals Living with HIV: A Review of Essential Vaccines, Vaccine Coverage, and Adherence Factors.
Vaccines (Basel). 2025 Jul 28;13(8):798. doi: 10.3390/vaccines13080798.
2
Antidepressants for depression in adults with HIV infection.
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD008525. doi: 10.1002/14651858.CD008525.pub3.
3
Inadequate immune response to inactivated COVID-19 vaccine among older people living with HIV: a prospective cohort study.
J Virol. 2025 Aug 21:e0068825. doi: 10.1128/jvi.00688-25.
4
COVID-19 Incidence and Factors Influencing Infection Risk Among People Living With HIV in Türkiye: Is Current Issue the Vaccine Hesitancy-Opposition?
Can J Infect Dis Med Microbiol. 2025 Aug 18;2025:6767853. doi: 10.1155/cjid/6767853. eCollection 2025.
5
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
6
Interventions for tobacco use cessation in people living with HIV.
Cochrane Database Syst Rev. 2024 Aug 5;8(8):CD011120. doi: 10.1002/14651858.CD011120.pub3.
7
Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials.
Clin Trials. 2025 Aug;22(4):442-451. doi: 10.1177/17407745251347280. Epub 2025 Jul 5.
8
Investigating factors affecting the effectiveness of Gardasil 4, Cervarix, and Gardasil 9 vaccines considering the WHO regions in females: A systematic review.
Cancer Epidemiol. 2025 Apr;95:102759. doi: 10.1016/j.canep.2025.102759. Epub 2025 Feb 5.
10
Understanding the views of adult migrants around catch-up vaccination for missed routine immunisations to define strategies to improve coverage: A UK in-depth interview study.
Vaccine. 2024 May 10;42(13):3206-3214. doi: 10.1016/j.vaccine.2024.04.005. Epub 2024 Apr 16.
本文引用的文献
1
A meta-analysis of immunogenicity and safety of two versus single-doses of influenza A (H1N1) vaccine in person living with HIV.
Int J STD AIDS. 2024 Apr;35(5):326-336. doi: 10.1177/09564624231220424. Epub 2023 Dec 12.
2
Vaccine development: Current trends and technologies.
Life Sci. 2024 Jan 1;336:122331. doi: 10.1016/j.lfs.2023.122331. Epub 2023 Dec 7.
3
Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study.
Microorganisms. 2023 Nov 3;11(11):2701. doi: 10.3390/microorganisms11112701.
4
Increasing hepatitis B vaccination coverage and decreasing hepatitis B co-infection prevalence among people with HIV-1 in Germany, 1996-2019. Results from a cohort study primarily in men who have sex with men.
HIV Med. 2024 Feb;25(2):201-211. doi: 10.1111/hiv.13554. Epub 2023 Oct 2.
5
Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV.
AIDS. 2023 Dec 1;37(15):2305-2310. doi: 10.1097/QAD.0000000000003731. Epub 2023 Oct 3.
6
Viral blips and virologic failures following mpox vaccination with MVA-BN among people with HIV.
AIDS. 2023 Dec 1;37(15):2365-2369. doi: 10.1097/QAD.0000000000003733. Epub 2023 Sep 28.
7
Mpox in people with past infection or a complete vaccination course: a global case series.
Lancet Infect Dis. 2024 Jan;24(1):57-64. doi: 10.1016/S1473-3099(23)00492-9. Epub 2023 Sep 4.
8
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV.
AIDS. 2023 Dec 1;37(15):2319-2329. doi: 10.1097/QAD.0000000000003696. Epub 2023 Aug 23.
9
Incidence of Anal Cancer and Related Risk Factors in HIV-Infected Patients Enrolled in the National Prospective Spanish Cohort CoRIS.
Dis Colon Rectum. 2023 Dec 1;66(12):e1186-e1194. doi: 10.1097/DCR.0000000000002940. Epub 2023 Aug 3.
10
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
N Engl J Med. 2023 Jun 29;388(26):2434-2443. doi: 10.1056/NEJMoa2215201. Epub 2023 May 18.
Zotero 插件